Informatie:
Fout:
ID
14484
Beschrijving
A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00628758
Link
https://clinicaltrials.gov/show/NCT00628758
Trefwoorden
Versies (1)
- 18-04-16 18-04-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
18 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Asthma NCT00628758
Eligibility Asthma NCT00628758
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00628758
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
informed consent form
Item
signed informed consent form. if the patient cannot read and write, verbal consent from the patient is required.
boolean
C0021430 (UMLS CUI [1])
turkish literacy
Item
ability to read and write in turkish
boolean
C0023864 (UMLS CUI [1,1])
C0041402 (UMLS CUI [1,2])
C0041402 (UMLS CUI [1,2])
outpatients aged 18 years
Item
female or male outpatients aged 18 years
boolean
C0001779 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
C0029921 (UMLS CUI [2])
history of asthma
Item
minimum of 3 months history of asthma, diagnosed according to the american thoracic society (ats) definition
boolean
C0262926 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
ics
Item
prescribed inhaled glucocorticosteroid (gcs) at a dose of 320mg/day and within the approved label for the relevant drug during the last 3 months prior to visit 1
boolean
C3248292 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
asthma treatment
Item
either: daily maintenance treatment with both inhaled gcs and long-acting b2-agonist (laba) or daily treatment with inhaled gcs alone (i.e. without laba); and a history of suboptimal asthma control the month prior to enrollment as judged by the investigator; and use of 3 peak expiratory flow inhalations ofas needed medication for symptom relief during the last 7 days before enrollment
boolean
C2065041 (UMLS CUI [1])
C0040223 (UMLS CUI [2])
C1373132 (UMLS CUI [3])
C0040223 (UMLS CUI [2])
C1373132 (UMLS CUI [3])
symbicort
Item
previous treatment with symbicort single inhaler therapy
boolean
C1121854 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
adrenergic beta-antagonists
Item
use of any b-blocking agent, including eye drops
boolean
C0001645 (UMLS CUI [1])
oral corticosteroid
Item
use of oral gcs as maintenance treatment
boolean
C0001617 (UMLS CUI [1])
hypersensitivity to study therapy or excipients
Item
known or suspected hypersensitivity to study therapy or excipients
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
smoking history
Item
a history of smoking 10 pack years
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C1277691 (UMLS CUI [2])
pregnancy lactation intention to become pregnant
Item
pregnancy, breast-feeding or planned pregnancy during the study. fertile women not using acceptable contraceptive measures, as judged by the investigator
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C0032961 (UMLS CUI [5,1])
C1283828 (UMLS CUI [5,2])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C0032961 (UMLS CUI [5,1])
C1283828 (UMLS CUI [5,2])
comorbidity limiting participation
Item
any significant disease or disorder, which, in the opinion of the investigator, may put the patient at risk because of participating in the study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])